Investigation Overview
April 3, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Proteon Therapeutics Inc (NASDAQ:PRTO) shares over potential securities laws violations by Proteon Therapeutics Inc and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of...
You must register (for free) or login to view the entire investigation.